| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Stomach Neoplasms | 9 | 2019 | 477 | 1.87 | Why? |
| Head and Neck Neoplasms | 6 | 2018 | 1568 | 1.31 | Why? |
| Health Systems Plans | 1 | 2020 | 56 | 0.82 | Why? |
| Genetic Predisposition to Disease | 8 | 2018 | 4027 | 0.81 | Why? |
| Mucin-6 | 1 | 2018 | 2 | 0.77 | Why? |
| Mucin 5AC | 1 | 2018 | 46 | 0.73 | Why? |
| Neoplasms, Multiple Primary | 2 | 2018 | 61 | 0.72 | Why? |
| Acetaldehyde | 1 | 2017 | 11 | 0.72 | Why? |
| Alcohol Dehydrogenase | 1 | 2017 | 19 | 0.72 | Why? |
| Genetics, Medical | 1 | 2019 | 64 | 0.71 | Why? |
| Holidays | 1 | 2021 | 311 | 0.69 | Why? |
| Body Height | 1 | 2018 | 100 | 0.68 | Why? |
| Mucin-1 | 1 | 2018 | 277 | 0.59 | Why? |
| Mendelian Randomization Analysis | 1 | 2018 | 317 | 0.59 | Why? |
| Helicobacter Infections | 1 | 2018 | 216 | 0.59 | Why? |
| Professional Competence | 1 | 2019 | 246 | 0.58 | Why? |
| Exercise | 5 | 2018 | 6771 | 0.58 | Why? |
| Polymorphism, Single Nucleotide | 3 | 2018 | 3607 | 0.58 | Why? |
| Helicobacter pylori | 1 | 2018 | 262 | 0.57 | Why? |
| Genome-Wide Association Study | 2 | 2018 | 1648 | 0.54 | Why? |
| Delphi Technique | 1 | 2019 | 1257 | 0.54 | Why? |
| Environmental Pollutants | 1 | 2018 | 320 | 0.51 | Why? |
| Diffusion of Innovation | 1 | 2017 | 440 | 0.50 | Why? |
| Capacity Building | 1 | 2019 | 683 | 0.49 | Why? |
| Biomarkers, Tumor | 2 | 2018 | 1314 | 0.48 | Why? |
| Safety Management | 1 | 2021 | 1093 | 0.48 | Why? |
| Alcohol Drinking | 4 | 2018 | 1663 | 0.47 | Why? |
| Ethanol | 1 | 2017 | 533 | 0.46 | Why? |
| Urinary Bladder Neoplasms | 1 | 2018 | 614 | 0.45 | Why? |
| Self Efficacy | 1 | 2017 | 717 | 0.44 | Why? |
| Environment | 1 | 2017 | 769 | 0.43 | Why? |
| Diet | 3 | 2019 | 2052 | 0.43 | Why? |
| Italy | 23 | 2021 | 38444 | 0.43 | Why? |
| Kidney Neoplasms | 2 | 2018 | 832 | 0.42 | Why? |
| Polymorphism, Genetic | 3 | 2017 | 1074 | 0.42 | Why? |
| Social Class | 1 | 2018 | 1360 | 0.38 | Why? |
| Precision Medicine | 1 | 2017 | 1477 | 0.33 | Why? |
| Tumor Suppressor Protein p53 | 1 | 2009 | 310 | 0.32 | Why? |
| State Medicine | 1 | 2020 | 2847 | 0.31 | Why? |
| MicroRNAs | 1 | 2018 | 1787 | 0.30 | Why? |
| Emergencies | 1 | 2020 | 4095 | 0.28 | Why? |
| Influenza Vaccines | 1 | 2021 | 2941 | 0.28 | Why? |
| Glutathione Transferase | 2 | 2018 | 86 | 0.26 | Why? |
| Models, Statistical | 1 | 2020 | 5312 | 0.25 | Why? |
| DNA Fingerprinting | 1 | 2002 | 41 | 0.24 | Why? |
| Students | 1 | 2021 | 5255 | 0.24 | Why? |
| DNA, Fungal | 1 | 2002 | 95 | 0.24 | Why? |
| Risk Assessment | 4 | 2021 | 25439 | 0.24 | Why? |
| Vaccination | 4 | 2021 | 19050 | 0.23 | Why? |
| Infant, Premature, Diseases | 1 | 2002 | 74 | 0.23 | Why? |
| Iron | 2 | 2017 | 619 | 0.22 | Why? |
| Candida albicans | 1 | 2002 | 217 | 0.21 | Why? |
| Health Personnel | 4 | 2021 | 29646 | 0.21 | Why? |
| Cross Infection | 2 | 2019 | 8675 | 0.21 | Why? |
| Hormone Replacement Therapy | 2 | 2018 | 146 | 0.21 | Why? |
| Humans | 59 | 2021 | 930598 | 0.20 | Why? |
| Europe | 7 | 2021 | 12702 | 0.20 | Why? |
| Occupational Exposure | 1 | 2018 | 4742 | 0.20 | Why? |
| Arylsulfotransferase | 1 | 2018 | 2 | 0.20 | Why? |
| Chlorine Compounds | 1 | 2018 | 18 | 0.19 | Why? |
| Citrus | 1 | 2019 | 29 | 0.19 | Why? |
| Arylamine N-Acetyltransferase | 1 | 2018 | 15 | 0.19 | Why? |
| Fruit and Vegetable Juices | 1 | 2019 | 32 | 0.19 | Why? |
| European Union | 2 | 2020 | 565 | 0.19 | Why? |
| Genes, BRCA2 | 1 | 2018 | 28 | 0.19 | Why? |
| Health Services Accessibility | 2 | 2020 | 10697 | 0.19 | Why? |
| Salpingo-oophorectomy | 1 | 2018 | 59 | 0.19 | Why? |
| Genes, BRCA1 | 1 | 2018 | 29 | 0.19 | Why? |
| Decision Trees | 1 | 2021 | 441 | 0.19 | Why? |
| Amines | 1 | 2018 | 67 | 0.19 | Why? |
| Adenocarcinoma, Mucinous | 1 | 2018 | 27 | 0.19 | Why? |
| Polycyclic Aromatic Hydrocarbons | 1 | 2018 | 30 | 0.19 | Why? |
| Legionella | 1 | 2018 | 91 | 0.18 | Why? |
| Oxides | 1 | 2018 | 77 | 0.18 | Why? |
| Female | 30 | 2021 | 380317 | 0.18 | Why? |
| Liability, Legal | 1 | 2021 | 198 | 0.18 | Why? |
| Hypopharyngeal Neoplasms | 1 | 2018 | 47 | 0.18 | Why? |
| X-ray Repair Cross Complementing Protein 1 | 1 | 2017 | 6 | 0.18 | Why? |
| Mental Disorders | 1 | 2021 | 6742 | 0.18 | Why? |
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2018 | 41 | 0.18 | Why? |
| Telomere Shortening | 1 | 2018 | 66 | 0.17 | Why? |
| Male | 27 | 2021 | 367725 | 0.17 | Why? |
| Education, Distance | 1 | 2019 | 4956 | 0.17 | Why? |
| Candidiasis | 1 | 2002 | 334 | 0.17 | Why? |
| Carcinoma, Papillary | 1 | 2018 | 76 | 0.17 | Why? |
| Candidiasis, Vulvovaginal | 1 | 2017 | 10 | 0.17 | Why? |
| Pesticides | 1 | 2018 | 100 | 0.17 | Why? |
| Economic Competition | 1 | 2017 | 35 | 0.17 | Why? |
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 45 | 0.17 | Why? |
| Hormones | 1 | 2017 | 66 | 0.17 | Why? |
| Delivery of Health Care | 3 | 2021 | 15909 | 0.17 | Why? |
| Carcinoma, Pancreatic Ductal | 1 | 2018 | 112 | 0.17 | Why? |
| Middle Aged | 24 | 2021 | 270681 | 0.17 | Why? |
| Aged | 21 | 2021 | 215776 | 0.16 | Why? |
| Publication Bias | 1 | 2018 | 241 | 0.16 | Why? |
| Drinking Water | 1 | 2018 | 145 | 0.16 | Why? |
| Human papillomavirus 16 | 1 | 2017 | 95 | 0.16 | Why? |
| Physicians | 3 | 2021 | 4214 | 0.16 | Why? |
| Genotype | 4 | 2017 | 4697 | 0.16 | Why? |
| Prognosis | 6 | 2021 | 32490 | 0.16 | Why? |
| Influenza, Human | 1 | 2021 | 10779 | 0.16 | Why? |
| Environmental Monitoring | 2 | 2018 | 3143 | 0.15 | Why? |
| Intensive Care Units, Neonatal | 1 | 2002 | 749 | 0.15 | Why? |
| Water Supply | 1 | 2018 | 294 | 0.15 | Why? |
| Toll-Like Receptor 2 | 1 | 2017 | 198 | 0.15 | Why? |
| Laryngeal Neoplasms | 1 | 2018 | 202 | 0.15 | Why? |
| Disease Outbreaks | 2 | 2020 | 27595 | 0.15 | Why? |
| Public Health | 2 | 2020 | 16359 | 0.15 | Why? |
| Pneumococcal Vaccines | 1 | 2021 | 571 | 0.15 | Why? |
| Gene Expression Regulation, Neoplastic | 2 | 2018 | 1014 | 0.14 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.14 | Why? |
| Rome | 3 | 2021 | 497 | 0.14 | Why? |
| Anemia, Iron-Deficiency | 1 | 2017 | 210 | 0.14 | Why? |
| Mouth Mucosa | 1 | 2017 | 323 | 0.14 | Why? |
| Genetic Testing | 1 | 2018 | 395 | 0.14 | Why? |
| Social Environment | 1 | 2017 | 389 | 0.14 | Why? |
| Neoplasm Staging | 2 | 2018 | 1999 | 0.13 | Why? |
| Tobacco Smoking | 1 | 2018 | 349 | 0.13 | Why? |
| Quarantine | 1 | 2021 | 18418 | 0.13 | Why? |
| Neuroendocrine Tumors | 1 | 2017 | 241 | 0.13 | Why? |
| Veins | 1 | 2014 | 168 | 0.13 | Why? |
| Diet, Mediterranean | 1 | 2017 | 351 | 0.12 | Why? |
| Case-Control Studies | 7 | 2019 | 17671 | 0.12 | Why? |
| Community Pharmacy Services | 1 | 2018 | 426 | 0.12 | Why? |
| Device Removal | 1 | 2014 | 221 | 0.12 | Why? |
| Adult | 16 | 2021 | 244371 | 0.11 | Why? |
| Erythrocytes | 1 | 2017 | 617 | 0.11 | Why? |
| Aged, 80 and over | 10 | 2021 | 88759 | 0.11 | Why? |
| Healthy Volunteers | 1 | 2017 | 1444 | 0.11 | Why? |
| Kaplan-Meier Estimate | 2 | 2018 | 4260 | 0.11 | Why? |
| Mouth Neoplasms | 1 | 2018 | 463 | 0.11 | Why? |
| Risk Reduction Behavior | 1 | 2018 | 946 | 0.11 | Why? |
| Pancreatic Neoplasms | 1 | 2018 | 609 | 0.11 | Why? |
| Neoplasm Recurrence, Local | 1 | 2018 | 1063 | 0.11 | Why? |
| Patient Preference | 1 | 2017 | 750 | 0.10 | Why? |
| Anemia | 1 | 2017 | 789 | 0.10 | Why? |
| Trust | 1 | 2020 | 1487 | 0.10 | Why? |
| Home Care Services | 1 | 2021 | 1351 | 0.10 | Why? |
| Pacemaker, Artificial | 1 | 2014 | 431 | 0.10 | Why? |
| Introns | 1 | 2009 | 112 | 0.10 | Why? |
| Community Health Services | 1 | 2018 | 1000 | 0.10 | Why? |
| International Cooperation | 2 | 2020 | 3436 | 0.10 | Why? |
| Young Adult | 8 | 2021 | 93724 | 0.10 | Why? |
| Crohn Disease | 1 | 2018 | 959 | 0.10 | Why? |
| Patients | 1 | 2017 | 1167 | 0.09 | Why? |
| Quality Improvement | 2 | 2019 | 2435 | 0.09 | Why? |
| Colitis, Ulcerative | 1 | 2018 | 1037 | 0.09 | Why? |
| Smoking | 3 | 2018 | 3358 | 0.09 | Why? |
| Risk Factors | 8 | 2021 | 71621 | 0.09 | Why? |
| Disinfectants | 1 | 2018 | 1077 | 0.09 | Why? |
| Biomedical Research | 2 | 2020 | 5270 | 0.09 | Why? |
| Schizophrenia | 1 | 2018 | 1018 | 0.09 | Why? |
| Psychotic Disorders | 1 | 2018 | 924 | 0.09 | Why? |
| Maltose | 2 | 2017 | 50 | 0.09 | Why? |
| Health Policy | 2 | 2018 | 6242 | 0.08 | Why? |
| Defibrillators, Implantable | 1 | 2014 | 624 | 0.08 | Why? |
| Adolescent | 6 | 2020 | 86841 | 0.08 | Why? |
| Colorectal Neoplasms | 2 | 2018 | 1884 | 0.08 | Why? |
| Gene Expression Profiling | 1 | 2018 | 3788 | 0.08 | Why? |
| Delivery of Health Care, Integrated | 1 | 2019 | 1549 | 0.08 | Why? |
| Carcinoma, Hepatocellular | 1 | 2017 | 1222 | 0.08 | Why? |
| Odds Ratio | 3 | 2018 | 5861 | 0.08 | Why? |
| Cost of Illness | 1 | 2017 | 1903 | 0.08 | Why? |
| Ferric Compounds | 2 | 2017 | 136 | 0.08 | Why? |
| Universities | 1 | 2021 | 4374 | 0.07 | Why? |
| Outpatients | 1 | 2019 | 3417 | 0.07 | Why? |
| Disease Progression | 2 | 2018 | 13580 | 0.07 | Why? |
| Internationality | 1 | 2018 | 3297 | 0.07 | Why? |
| Infant, Newborn | 3 | 2020 | 23105 | 0.07 | Why? |
| Health Services Needs and Demand | 1 | 2020 | 3419 | 0.07 | Why? |
| Haplotypes | 1 | 2009 | 853 | 0.07 | Why? |
| Disinfection | 1 | 2018 | 2912 | 0.07 | Why? |
| Feeding Behavior | 1 | 2017 | 1909 | 0.07 | Why? |
| Liver Neoplasms | 1 | 2017 | 1666 | 0.07 | Why? |
| Immunization Programs | 1 | 2018 | 2006 | 0.07 | Why? |
| Curriculum | 1 | 2019 | 3083 | 0.07 | Why? |
| Public Policy | 1 | 2017 | 1894 | 0.07 | Why? |
| Sex Factors | 2 | 2018 | 11014 | 0.07 | Why? |
| Gene Frequency | 1 | 2009 | 1210 | 0.07 | Why? |
| Prevalence | 4 | 2018 | 25773 | 0.07 | Why? |
| Algorithms | 1 | 2021 | 7346 | 0.06 | Why? |
| Breast Neoplasms | 2 | 2018 | 3633 | 0.06 | Why? |
| North America | 2 | 2019 | 1400 | 0.06 | Why? |
| Administration, Intravenous | 2 | 2017 | 1115 | 0.06 | Why? |
| Hospitals, Religious | 1 | 2002 | 9 | 0.06 | Why? |
| Inflammatory Bowel Diseases | 2 | 2017 | 3209 | 0.06 | Why? |
| Survival Rate | 1 | 2017 | 9206 | 0.06 | Why? |
| Alleles | 1 | 2009 | 1557 | 0.06 | Why? |
| Internet | 1 | 2021 | 6204 | 0.06 | Why? |
| Cohort Studies | 3 | 2021 | 36005 | 0.06 | Why? |
| Communication | 1 | 2020 | 5206 | 0.06 | Why? |
| Caregivers | 1 | 2017 | 3112 | 0.06 | Why? |
| Medical Oncology | 1 | 2019 | 3826 | 0.06 | Why? |
| Infant, Very Low Birth Weight | 1 | 2002 | 62 | 0.06 | Why? |
| Education, Medical | 1 | 2019 | 2461 | 0.06 | Why? |
| Child, Preschool | 3 | 2020 | 36283 | 0.06 | Why? |
| Patient Acceptance of Health Care | 1 | 2020 | 5002 | 0.06 | Why? |
| Decision Making, Computer-Assisted | 1 | 2021 | 61 | 0.05 | Why? |
| Hemoglobins | 2 | 2017 | 958 | 0.05 | Why? |
| Mental Health Services | 1 | 2018 | 3007 | 0.05 | Why? |
| Surveys and Questionnaires | 4 | 2021 | 43792 | 0.05 | Why? |
| Aging | 1 | 2017 | 3581 | 0.05 | Why? |
| Asia | 2 | 2019 | 2399 | 0.05 | Why? |
| Survival Analysis | 2 | 2018 | 7592 | 0.05 | Why? |
| Infant | 2 | 2020 | 30274 | 0.05 | Why? |
| Cross-Sectional Studies | 4 | 2021 | 53120 | 0.05 | Why? |
| Research Design | 1 | 2017 | 5830 | 0.05 | Why? |
| Meta-Analysis as Topic | 2 | 2017 | 1289 | 0.05 | Why? |
| United Kingdom | 1 | 2020 | 18046 | 0.05 | Why? |
| Disease Management | 1 | 2018 | 6841 | 0.05 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.05 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.05 | Why? |
| Vaccines | 1 | 2019 | 3692 | 0.05 | Why? |
| Respiratory Tract Infections | 1 | 2020 | 6817 | 0.05 | Why? |
| San Marino | 1 | 2018 | 3 | 0.05 | Why? |
| Health Knowledge, Attitudes, Practice | 2 | 2020 | 8811 | 0.05 | Why? |
| Task Performance and Analysis | 1 | 2019 | 68 | 0.05 | Why? |
| Patient Safety | 1 | 2014 | 4885 | 0.05 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.05 | Why? |
| Social Media | 1 | 2020 | 5798 | 0.05 | Why? |
| Reproductive History | 1 | 2017 | 7 | 0.05 | Why? |
| United States | 3 | 2021 | 46150 | 0.04 | Why? |
| Mutation | 1 | 2018 | 12376 | 0.04 | Why? |
| Fabaceae | 1 | 2017 | 39 | 0.04 | Why? |
| Menstrual Cycle | 1 | 2017 | 59 | 0.04 | Why? |
| Vulva | 1 | 2017 | 31 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2018 | 6166 | 0.04 | Why? |
| Fishes | 1 | 2017 | 99 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| Retrospective Studies | 5 | 2021 | 105322 | 0.04 | Why? |
| DNA Repair | 1 | 2017 | 114 | 0.04 | Why? |
| SEER Program | 1 | 2017 | 146 | 0.04 | Why? |
| Age Factors | 4 | 2018 | 21039 | 0.04 | Why? |
| Child | 3 | 2020 | 70012 | 0.04 | Why? |
| Proto-Oncogene Proteins B-raf | 1 | 2018 | 179 | 0.04 | Why? |
| Water Microbiology | 1 | 2018 | 248 | 0.04 | Why? |
| Molecular Epidemiology | 1 | 2002 | 1638 | 0.04 | Why? |
| Technology Assessment, Biomedical | 1 | 2017 | 106 | 0.04 | Why? |
| Hospitals, University | 2 | 2019 | 4173 | 0.04 | Why? |
| Menopause | 1 | 2017 | 136 | 0.04 | Why? |
| Neoplasm Grading | 1 | 2017 | 400 | 0.04 | Why? |
| Absenteeism | 1 | 2017 | 287 | 0.04 | Why? |
| Vegetables | 1 | 2017 | 340 | 0.04 | Why? |
| Efficiency, Organizational | 1 | 2019 | 482 | 0.04 | Why? |
| Arabs | 1 | 2017 | 298 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2019 | 15421 | 0.03 | Why? |
| Vagina | 1 | 2017 | 327 | 0.03 | Why? |
| Time Factors | 1 | 2017 | 31397 | 0.03 | Why? |
| Public-Private Sector Partnerships | 1 | 2017 | 259 | 0.03 | Why? |
| Genetic Association Studies | 1 | 2017 | 559 | 0.03 | Why? |
| Infusions, Intravenous | 1 | 2017 | 1224 | 0.03 | Why? |
| Prosthesis Failure | 1 | 2014 | 195 | 0.03 | Why? |
| Middle East | 1 | 2017 | 1418 | 0.03 | Why? |
| Candida | 1 | 2017 | 425 | 0.03 | Why? |
| Linear Models | 1 | 2019 | 1914 | 0.03 | Why? |
| Public Opinion | 1 | 2021 | 1165 | 0.03 | Why? |
| Patient Acuity | 1 | 2018 | 1755 | 0.03 | Why? |
| Health Services | 1 | 2017 | 765 | 0.03 | Why? |
| Prosthesis-Related Infections | 1 | 2014 | 302 | 0.03 | Why? |
| Regression Analysis | 1 | 2018 | 2484 | 0.03 | Why? |
| Health Planning | 1 | 2017 | 607 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2017 | 1887 | 0.03 | Why? |
| Administration, Oral | 1 | 2017 | 2340 | 0.02 | Why? |
| Monitoring, Physiologic | 1 | 2021 | 1956 | 0.02 | Why? |
| Academic Medical Centers | 1 | 2002 | 3088 | 0.02 | Why? |
| Hospitals | 2 | 2021 | 11793 | 0.02 | Why? |
| Netherlands | 1 | 2018 | 3533 | 0.02 | Why? |
| Drug Industry | 1 | 2017 | 689 | 0.02 | Why? |
| Antimalarials | 1 | 2020 | 2505 | 0.02 | Why? |
| Cost-Benefit Analysis | 1 | 2018 | 2259 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.02 | Why? |
| Health Care Surveys | 1 | 2017 | 2942 | 0.02 | Why? |
| Family Characteristics | 1 | 2017 | 2551 | 0.02 | Why? |
| Serologic Tests | 1 | 2021 | 4359 | 0.02 | Why? |
| Early Detection of Cancer | 1 | 2018 | 1956 | 0.02 | Why? |
| Employment | 1 | 2017 | 1754 | 0.02 | Why? |
| Prostatic Neoplasms | 1 | 2018 | 1637 | 0.02 | Why? |
| Incidence | 2 | 2018 | 25622 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.02 | Why? |
| Life Style | 1 | 2017 | 2708 | 0.02 | Why? |
| Risk | 1 | 2017 | 5288 | 0.02 | Why? |
| Machine Learning | 1 | 2021 | 4395 | 0.02 | Why? |
| Immunologic Factors | 1 | 2020 | 4206 | 0.02 | Why? |
| Germany | 1 | 2018 | 9196 | 0.02 | Why? |
| Follow-Up Studies | 1 | 2021 | 17020 | 0.01 | Why? |
| Spain | 1 | 2018 | 15545 | 0.01 | Why? |
| Socioeconomic Factors | 1 | 2017 | 8495 | 0.01 | Why? |
| Brazil | 1 | 2017 | 12582 | 0.01 | Why? |
| Viral Vaccines | 1 | 2020 | 7560 | 0.01 | Why? |
| Mass Screening | 1 | 2018 | 8005 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2017 | 7330 | 0.01 | Why? |
| Comorbidity | 1 | 2018 | 34796 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Infection Control | 1 | 2002 | 23131 | 0.01 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2017 | 48226 | 0.01 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.01 | Why? |
| Animals | 1 | 2017 | 78931 | 0.01 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.01 | Why? |